Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 32

1.

Comparison of RNA extraction kits and histological stains for laser capture microdissected prostate tissue.

Kolijn K, van Leenders GJ.

BMC Res Notes. 2016 Jan 7;9:17. doi: 10.1186/s13104-015-1813-5.

2.

High frequency of the SDK1:AMACR fusion transcript in Chinese prostate cancer.

Zhang Y, Mao XY, Liu X, Song RR, Berney D, Lu YJ, Ren G.

Int J Clin Exp Med. 2015 Sep 15;8(9):15127-36. eCollection 2015.

3.

Novel In Vivo model for combinatorial fluorescence labeling in mouse prostate.

Fang X, Gyabaah K, Nickkholgh B, Cline JM, Balaji KC.

Prostate. 2015 Jun 15;75(9):988-1000. doi: 10.1002/pros.22984. Epub 2015 Mar 8.

4.

Cell type specific gene expression analysis of prostate needle biopsies resolves tumor tissue heterogeneity.

Krönig M, Walter M, Drendel V, Werner M, Jilg CA, Richter AS, Backofen R, McGarry D, Follo M, Schultze-Seemann W, Schüle R.

Oncotarget. 2015 Jan 20;6(2):1302-14.

5.

AMACR amplification and overexpression in primary imatinib-naïve gastrointestinal stromal tumors: a driver of cell proliferation indicating adverse prognosis.

Li CF, Chen LT, Lan J, Chou FF, Lin CY, Chen YY, Chen TJ, Li SH, Yu SC, Fang FM, Tai HC, Huang HY.

Oncotarget. 2014 Nov 30;5(22):11588-603.

6.

Dietary influences on tissue concentrations of phytanic acid and AMACR expression in the benign human prostate.

Kataria Y, Wright M, Deaton RJ, Rueter EE, Rybicki BA, Moser AB, Ananthanrayanan V, Gann PH.

Prostate. 2015 Feb;75(2):200-10. doi: 10.1002/pros.22905. Epub 2014 Oct 13.

7.

Utility of α-methylacyl-coenzyme-A racemase (p504s) immunohistochemistry in distinguishing endometrial clear cell carcinomas from serous and endometrioid carcinomas.

Fadare O, Parkash V, Gwin K, Hanley KZ, Jarboe EA, Liang SX, Quick CM, Zheng W, Rawish KR, Hecht JL, Desouki MM.

Hum Pathol. 2013 Dec;44(12):2814-21. doi: 10.1016/j.humpath.2013.07.033. Epub 2013 Oct 10.

8.

Circulating Prostate Cells Found in Men with Benign Prostate Disease Are P504S Negative: Clinical Implications.

Murray NP, Reyes E, Badínez L, Orellana N, Fuentealba C, Olivares R, Porcell J, Dueñas R.

J Oncol. 2013;2013:165014. doi: 10.1155/2013/165014. Epub 2013 Apr 17.

9.

Phytanic acid and the risk of non-Hodgkin lymphoma.

Ollberding NJ, Aschebrook-Kilfoy B, Caces DB, Wright ME, Weisenburger DD, Smith SM, Chiu BC.

Carcinogenesis. 2013 Jan;34(1):170-5. doi: 10.1093/carcin/bgs315. Epub 2012 Oct 5.

10.

Interrogating genomic and epigenomic data to understand prostate cancer.

Kim J, Yu J.

Biochim Biophys Acta. 2012 Apr;1825(2):186-96. doi: 10.1016/j.bbcan.2011.12.003. Epub 2012 Jan 3. Review.

11.

High-throughput screen identifies novel inhibitors of cancer biomarker α-methylacyl coenzyme A racemase (AMACR/P504S).

Wilson BA, Wang H, Nacev BA, Mease RC, Liu JO, Pomper MG, Isaacs WB.

Mol Cancer Ther. 2011 May;10(5):825-38. doi: 10.1158/1535-7163.MCT-10-0902. Epub 2011 Mar 25.

12.

Clinicopathologic and immunohistochemical profile of ovarian metastases from colorectal carcinoma.

Kir G, Gurbuz A, Karateke A, Kir M.

World J Gastrointest Surg. 2010 Apr 27;2(4):109-16. doi: 10.4240/wjgs.v2.i4.109.

13.

Non-synonymous variants in the AMACR gene are associated with schizophrenia.

Bespalova IN, Durner M, Ritter BP, Angelo GW, Rossy-Fullana E, Carrion-Baralt J, Schmeidler J, Silverman JM.

Schizophr Res. 2010 Dec;124(1-3):208-15. doi: 10.1016/j.schres.2010.08.040. Epub 2010 Sep 26.

14.

Cancer biomarker discovery: the entropic hallmark.

Berretta R, Moscato P.

PLoS One. 2010 Aug 18;5(8):e12262. doi: 10.1371/journal.pone.0012262.

15.

AMACR is associated with advanced pathologic risk factors in sporadic colorectal adenomas.

Lakis S, Papamitsou T, Panagiotopoulou C, Kotakidou R, Kotoula V.

World J Gastroenterol. 2010 May 28;16(20):2476-83.

16.

Chromosome 5p Region SNPs Are Associated with Risk of NSCLC among Women.

Van Dyke AL, Cote ML, Wenzlaff AS, Abrams J, Land S, Iyer P, Schwartz AG.

J Cancer Epidemiol. 2009;2009:242151. doi: 10.1155/2009/242151. Epub 2010 Feb 18.

17.

Molecular mapping of tumor heterogeneity on clinical tissue specimens with multiplexed quantum dots.

Liu J, Lau SK, Varma VA, Moffitt RA, Caldwell M, Liu T, Young AN, Petros JA, Osunkoya AO, Krogstad T, Leyland-Jones B, Wang MD, Nie S.

ACS Nano. 2010 May 25;4(5):2755-65. doi: 10.1021/nn100213v.

18.

Fine-scale variation and genetic determinants of alternative splicing across individuals.

Coulombe-Huntington J, Lam KC, Dias C, Majewski J.

PLoS Genet. 2009 Dec;5(12):e1000766. doi: 10.1371/journal.pgen.1000766. Epub 2009 Dec 11.

19.

ETS gene fusions and prostate cancer.

Huang W, Waknitz M.

Am J Transl Res. 2009 May 25;1(4):341-51.

20.

Deletion hotspots in AMACR promoter CpG island are cis-regulatory elements controlling the gene expression in the colon.

Zhang X, Leav I, Revelo MP, Deka R, Medvedovic M, Jiang Z, Ho SM.

PLoS Genet. 2009 Jan;5(1):e1000334. doi: 10.1371/journal.pgen.1000334. Epub 2009 Jan 16.

Items per page

Supplemental Content

Write to the Help Desk